Clinical Trials · NCT02594072
Androgen Suppression With Stereotactic Body or External Beam Radiation Therapy (ASSERT)
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- University of British Columbia
- Enrollment
- 80
- Start date
- Apr 2016
- Locations
- 2 sites, Canada
- Primary endpoint
- Number of subjects experiencing treatment-related acute and late toxicities, focussing on grade 3 and 4 complications, as assessed by the NCI CTCAEv4 and modified RTOG/SOMA toxicity scale.